Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. European Institute of Oncology

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

European Institute of Oncology is an internationally renowned, non-profit comprehensive cancer center. Founded in 1994 by the prominent breast cancer surgeon and scientist Professor Umberto Veronesi, the institute operates as a recognized research hospital and treatment center (IRCCS). It seamlessly integrates cutting-edge basic and translational research with clinical prevention, diagnosis, patient care, and professional training. Hosting over 1,500 specialists, the campus features state-of-the-art infrastructure, including the highly advanced IEO Proton Center opened in 2023. Recognized globally for pioneering multidisciplinary oncological protocols and specialized surgical techniques, it stands as one of Europe’s leading anti-cancer institutions.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Cancer treatment center

Business Subcategory

Source: Human-provided. Cancer treatment center
Source: Trial-derived.
279Total Trials
Source: Trial-derived.
65Recruiting Trials
Source: Trial-derived.
80Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
347Unique Conditions
Source: Trial-derived.
189Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (18)Source: Trial-derived. Melanoma (15)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (13)Source: Trial-derived. Ovarian Cancer (9)Source: Trial-derived. Endometrial Cancer (6)Source: Trial-derived. Head and Neck Cancer (6)Source: Trial-derived. Metastatic Breast Cancer (6)Source: Trial-derived. Breast Neoplasms (5)

Sponsors

Source: Trial-derived. Merck Sharp & Dohme LLC (27)Source: Trial-derived. Hoffmann-La Roche (26)Source: Trial-derived. European Institute of Oncology (25)Source: Trial-derived. Pfizer (11)Source: Trial-derived. Regeneron Pharmaceuticals (11)Source: Trial-derived. AbbVie (10)Source: Trial-derived. Janssen Research & Development, LLC (9)Source: Trial-derived. Italian Sarcoma Group (8)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT
Source: AI-inferred. SPECT / nuclear medicine
Source: AI-inferred. Echocardiography

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Surgery / operating room
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Tumour EGFR mutation testing
Source: AI-inferred. Minimal residual disease (MRD) testing
Source: AI-inferred. RAS mutation testing
Source: AI-inferred. Tumour BRAF V600 mutation testing